首页 > 分享 > 鞣花酸对骨关节炎的保护作用及相关机制的研究

鞣花酸对骨关节炎的保护作用及相关机制的研究

花匠小妙招
2025-05-23 04:08

reference正文参考文献 [1]. French H P, Galvin R, Horgan N F, et al. Prevalence and burden of osteoarthritis amongst older people in Ireland: findings from The Irish LongituDinal Study on Ageing (TILDA). Osteoarthritis & Cartilage 2015, 23(1): A188. [2]. N. E. Lane, K. Shidara, B. L. Wise. Osteoarthritis year in review 2016: clinical. Osteoarthritis cartilage 2017, 25, 209– 215. [3]. S. Thysen, F.P. Luyten, R.J. Lories. Targets, models and challenges in osteoarthritis research. Dis. Model. Mech 8 (1) (2015) 17–30. [4]. S. Glyn-Jones, A. J. Palmer, R. Agricola, et al. Osteoarthritis. Lancet 2015, 386, 376–387. [5]. V.L. Johnson, D.J. Hunter. The epidemiology of osteoarthritis . Best Pract. Res. Clin. Rheumatol 28 (2014) 5–15. [6]. Shen CL, Smith BJ, Lo DF. Dietary polyphenols and mechanisms of osteoarthritis. The Journal of Nutritional Biochemistry 2012, 23(11):1367-1377. [7]. M. Daheshia, J.Q. Yao. The interleukin 1β pathway in the pathogenesis of osteoarthritis. Rheumatol 35 (12) (2008) 2306–2312. [8]. M.B. Goldring, K. Fukuo, J.R. Birkhead, , et al.Transcriptional suppression by interleukin-1 and interferon-gamma of type II collagen gene expression in human chondrocytes. Cell. Biochem 54 (1994) 85–99. [9]. K. S. Santangelo, G. J. Nuovo and A. L. Bertone. In vivo reduction or blockade of interleukin-1β in primary osteoarthritis influences expression of mediators implicated in pathogenesis. Osteoarthr. Cartil 2012, 20, 1610-1618. [10]. S. Lu, X. Xiao, M. Cheng. Matrine inhibits IL-1beta-induced expression of matrix metalloproteinases by suppressing the activation of MAPK and NF-kappaB in human chondrocytes in vitro. Int. J. Clin. Exp. Pathol 8 (5) (May 1 2015) 4764–4772. [11]. M. Shakibaei, C. Csaki, S. Nebrich, et al. Resveratrol suppresses interleukin-1betainduced inflammatory signaling and apoptosis in human articular chondrocytes: potential for use as a novel nutraceutical for the treatment of osteoarthritis. Biochem. Pharmacol 76 (11) (Dec 1 2008) 1426–1439. [12]. B. Hoesel, J. A. Schmid. The complexity of NF-kappaB signaling in inflammation and cancer. Molecular cancer 2013, 12, 86. [13]. G Yang, S Li, L Yuan, et al. Effect of nobiletin on the MAPK/NF-κB signaling pathway in the synovial membrane of rats with arthritis induced by collagen. Food & Function 2017, 8(12). [14]. Rigoglou, S., Papavassiliou, A. The NF-κB signalling pathway in osteoarthritis. Int. J. Biochem. Cell Biol 45, 2580–2584. [15]. Liacini, A., Sylvester, J., Li, W. Q. , et al. Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes. Matrix Biol 21, 251–262. [16]. G Yang, S Li, L Yuan, et al. Effect of nobiletin on the MAPK/NF-κB signaling pathway in the synovial membrane of rats with arthritis induced by collagen. Food & Function 2017, 8(12). [17]. J. B. Calixto, A. Beirith, J. Ferreira, ,et al. “Naturally occurring antinociceptive substances from plants,” . Phytotherapy Research vol. 14, no. 6, pp. 401–418, 2000. [18]. Lei Gu, Wen-sheng Deng, Ye Liu, et al. Ellagic acid protects Lipopolysaccharide/D-galactosamine-induced acute hepatic injury in mice. International Immunopharmacology 22 (2014) 341–345. [19]. Kuo MY, Ou HC, Lee WJ, et al. Ellagic Acid Inhibits Oxidized Low-Density Lipoprotein (OxLDL)-Induced Metalloproteinase (MMP) Expression by Modulating the Protein Kinase C-r/Extracellular Signal-Regulated Kinase/ Peroxisome Proliferator-Activated Receptor γ/Nuclear Factor-KB (PKC-r/ERK/PPAR-γ/NF-KB) Signaling Pathway in Endothelial Cells[. J Agric Food Chem 2011 May 11;59(9):5100-8. [20]. Al-Obaidi MM, Al-Bayaty FH, Al Batran R, et al. Protective effect of ellagic acid on healing alveolar bone after tooth extraction in rat--a histological and immunohistochemical study. Arch. Oral Biol 2014 Sep;59(9). [21]. Lei Gu, Wen-sheng Deng, Ye Liu, et al. Ellagic acid protects Lipopolysaccharide/D-galactosamine-induced acute hepatic injury in mice. International Immunopharmacology 2014 Oct;22(2):341-5. [22]. Aslan A, Hussein YT, Gok O, et al. Ellagic acid ameliorates lung damage in rats via modulating antioxidant activities, inhibitory effects on inflammatory mediators and apoptosis-inducing activities. Environ Sci Pollut Res Int 2020 Mar;27(7):7526-7537. [23]. B. Poulet, K. A. Staines. New developments in osteoarthritis and cartilage biology. Current opinion in pharmacology 2016, 28, 8-13. [24]. R.D. Altman, Practical considerations for the pharmacologic management of osteoarthritis. Am. J. Manag. Care 15 (8 Suppl) (2009) S236–S243. [25]. Loeser R F. Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix. Osteoarthritis Cartilage 2009, 17(8):971-979. [26]. Chen WH, Lo WC, Hsu WC, et al. Synergistic anabolic actions of hyaluronic acid and platelet-rich plasma on cartilage regeneration in osteoarthritis therapy. Biomaterials 2014 Dec;35(36):9599-607. [27]. Griffin TM, Scanzello CR. Innate inflammation and synovial macrophages in osteoarthritis pathophysiology. Clin Exp Rheumatol 2019 Sep-Oct;37 Suppl 120(5):57-63. Epub 2019 Oct 15. [28]. DeGroot J, Verzijl N, Bank RA,et al. Age-related decrease in proteoglycan synthesis of human articular chondrocytes: the role of nonenzymatic glycation. Arthritis Rheum 1999 May;42(5):1003-9. [29]. Barnett R. Osteoarthritis. Lancet. 2018 May 19;391(10134):1985. [30]. Stoppoloni D, Politi L, Leopizzi M, et al. Effect of glucosamine and its peptidyl-derivative on the production of extracellular matrix components by human primary chondrocytes. Osteoarthritis Cartilage 2015 Jan;23(1):103-13. [31]. Miller LE, Fredericson M, Altman RD. Hyaluronic Acid Injections or Oral Nonsteroidal Anti-inflammatory Drugs for Knee Osteoarthritis: Systematic Review and Meta-analysis of Randomized Trials. Orthop J Sports Med 2020 Jan 27;8(1):2325967119897909. [32]. van den Bosch MHJ, van Lent PLEM, van der Kraan PM. Identifying effector molecules, cells, and cytokines of innate immunity in OA. Osteoarthritis Cartilage 2020 Feb 7. pii: S1063-4584(20)30050-9. [33]. Ahmad N, Ansari MY, Haqqi TM. Role of iNOS in osteoarthritis: Pathological and therapeutic aspects. J Cell Physiol 2020 Feb 4. doi: 10.1002/jcp.29607. [34]. Zha Z, Han Q, Huo S. The protective effects of bexarotene against advanced glycation end-product (AGE)-induced degradation of articular extracellular matrix (ECM). Artif Cells Nanomed Biotechnol 2020 Dec;48(1):1-7. [35]. Wang Y, Nguyen UDT, Lane NE, et al. Knee osteoarthritis, potential mediators, and risk of all-cause mortality: data from the Osteoarthritis Initiative. Arthritis Care Res (Hoboken) 2020 Jan 21. [36]. Gil C, Abdoul H, Campagna R, et al. Intra-articular botulinum toxin A for base-of-thumb osteoarthritis: protocol for a randomised trial (RHIBOT). BMJ Open 2018 Jun 30;8(6):e022337. [37]. Rego-Pérez I, Durán-Sotuela A, Ramos-Louro P, et al. Mitochondrial Genetics and Epigenetics in Osteoarthritis. Front Genet 2020 Jan 17;10:1335. [38]. Bae KJ, Jang HS, Gong HS, et al. Prevalence and distribution of MRI abnormalities in the articular cartilage and supporting ligaments in patients with early clinical stage first carpometacarpal joint osteoarthritis. Skeletal Radiol 2020 Feb 1. [39]. Karlsson S, Nanberg E, Fjaeraa C, et al. Ellagic acid inhibits lipopolysaccharide-induced expression of enzymes involved in the synthesis of prostaglandin E2 in human monocytes. Br J Nutr 2010;103:1102–9. [40]. Chao PC, Hsu CC, Yin MC. Anti-inflammatory and anti-coagulatory activities of caffeic acid and ellagic acid in cardiac tissue of diabetic mice. Nutr Metab 2009;6:33. [41]. Bell, C.; Hawthorne, S. Ellagic acid, pomegranate and prostate cancer mini review. Pharm. Pharmacol 2008, 60 (2), 139?144. [42]. Suzuki N, Masamune A, Kikuta K, , et al. Ellagic acid inhibits pancreatic fibrosis in male Wistar Bonn/Kobori rats. Dig Dis Sci 2009;54:802–10. [43]. Lee, J. H, Won, J. H, Choi, J. M, et al. Protective Effect of Ellagic Acid on Concanavalin A-Induced Hepatitis via Toll-Like 522 Receptor and Mitogen-Activated Protein Kinase/Nuclear Factor kappaB Signaling Pathways. Agric Food Chem 2014, 62, 10110-7. [44]. Hwang, J. M., et al. Ellagic acid protects hepatocytes from damage by inhibiting mitochondrial production of reactive oxygen species. Biomed. Pharmacother 2010, 64 (4), 264?270. [45]. Rosillo MA, Sanchez-Hidalgo M, Cárdeno A, et al. Protective effect of ellagic acid, a natural polyphenolic compound, in a murine model of Crohn's disease. Biochem Pharmacol 2011 Oct 1;82(7):737-45. [46]. Ou HC, Lee WJ, Lee SD, et al. Ellagic acid protects endothelial cells from oxidized low-density lipoprotein-induced apoptosis by modulating the PI3K/Akt/eNOS pathway. Toxicol Appl Pharmacol 2010 Oct 15;248(2):134-43. [47]. Zhang M, Theleman JL, Lygrisse KA, et al. Epigenetic Mechanisms Underlying the Aging of Articular Cartilage and Osteoarthritis . Gerontology 2019;65(4). [48]. M. Varela-Eirin, A. Varela-Vazquez, A. Guitian-Caamano, , et al. Targeting of chondrocyte plasticity via connexin43 modulation attenuates cellular senescence and fosters a pro-regenerative environment in osteoarthritis. Cell Death Dis 2018 Dec 5;9(12):1166. [49]. N M-F, JB A, DE M, JE A, QW X, CF N, et al. Suppression of arthritis by an inhibitor of nitric oxide synthase. Journal of Experimental Medicine. 1993;178(2):749-54. [50]. Blanco FJ, Lotz M. IL-1-Induced Nitric Oxide Inhibits Chondrocyte Proliferation via PGE2. Experimental Cell Research. 1995;218(1):319-25. [51]. Loeser R F. Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix [J]. Osteoarthritis Cartilage, 2009, 17(8):971-979. [52]. Jiang L, Xu K, Li J, et al. Nesfatin-1 suppresses interleukin-1β-induced inflammation, apoptosis, and cartilage matrix destruction in chondrocytes and ameliorates osteoarthritis in rats. Aging (Albany NY) 2020 Jan 30;12(2):1760-1777. [53]. Tu C, Ma Y, Song M, et al. Liquiritigenin inhibits IL-1β-induced inflammation and cartilage matrix degradation in rat chondrocytes. Eur J Pharmacol 2019 Sep 5;858:172445. [54]. Zeng RM, Lu XH, Lin J, et al. Knockdown of FOXM1 attenuates inflammatory response in human osteoarthritis chondrocytes. Int Immunopharmacol 2019 Mar;68:74-80. [55]. Verma P, Dalal K. ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis. J Cell Biochem 2011 Dec;112(12):3507-14. [56]. Li P, Fleischhauer L, Nicolae C, et al. Mice Lacking the Matrilin Family of Extracellular Matrix Proteins Develop Mild Skeletal Abnormalities and Are Susceptible to Age-Associated Osteoarthritis. Int J Mol Sci 2020 Jan 19;21(2). pii: E666. [57]. Xi Y, Huang X, Tan G, et al. Protective effects of Erdosteine on interleukin-1β-stimulated inflammation via inhibiting the activation of MAPK, NF-κB, and Wnt/β-catenin signaling pathways in rat osteoarthritis. Eur J Pharmacol 2020 Jan 17;873:172925. [58]. Dai M, Sui B, Xue Y, et al. Cartilage repair in degenerative osteoarthritis mediated by squid type II collagen via immunomodulating activation of M2 macrophages, inhibiting apoptosis and hypertrophy of chondrocytes. Biomaterials 2018 Oct;180:91-103. [59]. Miller RE, Ishihara S, Tran PB, et al. An aggrecan fragment drives osteoarthritis pain through Toll-like receptor 2. JCI Insight 2018 Mar 22;3(6). [60]. Liu Y, Li X, Jin A. Rapamycin Inhibits Nf-ΚB Activation by Autophagy to Reduce Catabolism in Human Chondrocytes. J Invest Surg 2019 Apr 4:1-13. [61]. H. Zhi-Chao, X. Zhong-Jie, T. Qian, et al. Hydroxysafflor yellow A (HSYA) targets the NF-κB and MAPK pathways and ameliorates the development of osteoarthritis. Food Funct 2018, 9, 4443–4456. [62]. Lepetsos P, Papavassiliou KA, Papavassiliou AG. Redox and NF-κB signaling in osteoarthritis. Free Radic Biol Med 2019 Feb 20;132:90-100. [63]. Yang G, Wang Y, Chen Y, et al. UFL1 attenuates IL-1β-induced inflammatory response in human osteoarthritis chondrocytes. Int Immunopharmacol 2020 Feb 9;81:106278. [64]. Lee SA, Park BR, Moon, et al. SMChondroprotective Effect of Cynaroside in IL-1β-Induced Primary Rat Chondrocytes and Organ Explants via NF-κB and MAPK Signaling Inhibition. Oxid Med Cell Longev 2020 Jan 24;2020:9358080. 综述参考文献 [1]. Blagojevic M, Jinks C, Jeffery A, et al. Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis. Osteoarthritis Cartilage 2010 Jan;18(1):24-33. [2]. Silverwood V, Blagojevic-Bucknall M, Jinks C, et al. Current evidence on risk factors for knee osteoarthritis in older adults: a systematic review and meta-analysis. Osteoarthritis Cartilage 2015 Apr;23(4):507-15. [3]. Roman-Blas JA, Bizzi E, Largo R, et al. An update on the up and coming therapies to treat osteoarthritis, a multifaceted disease. Expert Opin Pharmacother 2016 Sep;17(13):1745-56. [4]. Kloppenburg M, Berenbaum F. Osteoarthritis Cartilage 2019，S1063-4584(20)30007-8. [5]. Chapman K, Valdes AM. Genetic factors in OA pathogenesis. Bone 2012，51(2):258–264. [6]. Xing D, Xu Y, Liu Q, et al. Osteoarthritis and all-cause mortality in worldwide populations: grading the evidence from a meta-analysis. Sci Rep 2016 Apr 18;6:24393. [7]. Altman RD. Practical considerations for the pharmacologic management of osteoarthritis. Am J Manag Care 2009 Sep;15(8 Suppl):S236-43. [8]. Hunt MA, Charlton JM, Esculier JF. Osteoarthritis year in review 2019: mechanics. Osteoarthritis Cartilage 2019 Dec 23. pii: S1063-4584(19)31297-X. [9]. Aicher WK1, Rolauffs B. The spatial organisation of joint surface chondrocytes: review of its potential roles in tissue functioning, disease and early, preclinical diagnosis of osteoarthritis. Ann Rheum Dis 2014 Apr;73(4):645-53. [10]. Selene Pérez-García, Mar Carrión, Irene Gutiérrez-Ca?as, et al. Profile of Matrix-Remodeling Proteinases in Osteoarthritis: Impact of Fibronectin. Cells 2019 Dec 22;9(1). [11]. Ukachukwu V, Duncan R, Belcher J，et al. Clinical Significance of Medial Versus Lateral Compartment Patellofemoral Osteoarthritis: Cross-Sectional Analyses in an Adult Population With Knee Pain. Arthritis Care Res (Hoboken) 2017 Jul;69(7):943-951. [12]. Wang T, He C. Pro-inflammatory cytokines: The link between obesity and osteoarthritis. Cytokine Growth Factor Rev 2018 Dec;44:38-50. [13]. Kulkarni K, Karssiens T, Kumar V. Obesity and osteoarthritis. Maturitas 2016 Jul;89:22-8. [14]. Fenton A, Panay N. Estrogen, menopause and joints. Climacteric 2016 Apr;19(2):107-8. [15]. Xu X, Li X, Liang Y. Estrogen Modulates Cartilage and Subchondral Bone Remodeling in an Ovariectomized Rat Model of Postmenopausal Osteoarthritis. Med Sci Monit 2019 Apr 29;25:3146-3153. [16]. Gelber AC. Osteoarthritis research: current state of the evidence. Curr Opin Rheumatol 2015,27(3):273-5. [17]. Rahmati M, Nalesso G, Mobasheri A, et al. Aging and osteoarthritis: Central role of the extracellular matrix. Ageing Res Rev. 2017 Nov;40:20-30. [18]. Wilusz RE, Sanchez-Adams J, Guilak F. The structure and function of the pericellular matrix of articular cartilage. Matrix Biol 2014 Oct;39:25-32. [19]. A Naba, KR Clauser, H Ding, et al. The extracellular matrix: tools andinsights for the “?mics” era. Matrix Biol 2016 Jan; 49;10–24. [20]. Au RY, Al-Talib TK, Au AY, et al. Avocado soybean unsaponifiables (ASU) suppress TNF-alpha, IL-1beta, COX-2, iNOS gene expression, and prostaglandin E2 and nitric oxide production in articular chondrocytes and monocyte/macrophages. Osteoarthritis Cartilage 2007 Nov; 15(11):1249-55. [21]. Schwager J, Richard N, Fowler A, et al. Carnosol and Related Substances Modulate Chemokine and Cytokine Production in Macrophages and Chondrocytes. Molecules 2016 Apr 08;21(4):465.16. [22]. Daheshia M, Yao JQ. The interleukin 1beta pathway in the pathogenesis of osteoarthritis. J Rheumatol 2008,35(12):2306-12. [23]. Santangelo KS, Nuovo GJ, Bertone AL. In vivo reduction or blockade of interleukin-1β in primary osteoarthritis influences expression of mediators implicated in pathogenesis. Osteoarthritis Cartilage 2012;20(12):1610-8. [24]. Daheshia M, Yao JQ. The interleukin 1beta pathway in the pathogenesis of osteoarthritis. J Rheumatol 2008;35(12):2306-12. [25]. Goldring, S. R.,Goldring, M. B. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin. Orthop. Relat. Res 2004,427, S27–S36. [26]. Goldring, M. B., Fukuo, K., et al. Transcriptional suppression by interleukin-1 and interferon-gamma of type II collagen gene expression in human chondrocytes. J. Cell Biochem 1994 Jan;54(1):85-99. [27]. Idriss HT, Naismith JH. TNF alpha and the TNF receptor superfamily: structure-function relationship(s). Microsc Res Tech 2000,50(3):184-95. [28]. Fuccelli R, Fabiani R, Sepporta MV, et al. The hydroxytyrosol-dependent increase of TNF-α in LPS-activated human monocytes is mediated by PGE2 and adenylate cyclase activation. Toxicol In Vitro 2015 Aug;29(5):933-7. [29]. Kapoor M, Martel-Pelletier J, Lajeunesse D, et al. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 2011;7(1):33-42. [30]. Au, R. Y., Al-Talib, T. K.,et al. Avocado soybean unsaponifables (ASU) suppress TNF-alpha, IL-1beta, COX-2, iNOS gene expression, and prostaglandin E2 and nitric oxide production in articular chondrocytes and monocyte/macrophages. Osteoarthritis Cartilage. 2007 Nov;15(11):1249-55. [31]. El-Haj L, Bestle MH. Nitric oxide and sepsis. Ugeskr Laeger 2017;30;179(44). [32]. Zheng G, Zhan Y, Tang Q, et al. Monascin inhibits IL-1β induced catabolism in mouse chondrocytes and ameliorates murine osteoarthritis. Food Funct 2018 Mar 1;9(3):1454-1464. [33]. Park JY, Pillinger MH, Abramson SB. Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases. Clin Immunol 2006 Jun;119(3):229-40. [34]. Kats A1, Norg?rd M, Wondimu Z,et al. Aminothiazoles inhibit RANKL- and LPS-mediated osteoclastogenesis and PGE2 production in RAW 264.7 cells. J Cell Mol Med 2016 Jun;20(6):1128-38. [35]. Lutter AH, Hempel U, Anderer U,et al. Biphasic influence of PGE2 on the resorption activity of osteoclast-like cells derived from human peripheral blood monocytes and mouse RAW264.7 cells. Prostaglandins Leukot Essent Fatty Acids. 2016;111:1-7. [36]. Riegger J, Brenner RE. Evidence of necroptosis in osteoarthritic disease: investigation of blunt mechanical impact as possible trigger in regulated necrosis. Cell Death Dis 2006 Jun;119(3):229-40. [37]. Withrow J, Murphy C, Liu Y,et al. Extracellular vesicles in the pathogenesis of rheumatoid arthritis and osteoarthritis. Arthritis Res Ther 2016 Dec 1;18(1):286. [38]. Tu C, Huang X, Xiao Y,et al. Schisandrin A Inhibits the IL-1β-Induced Inflammation and Cartilage Degradation via Suppression of MAPK and NF-κB Signal Pathways in Rat Chondrocytes. Front Pharmacol 2019 Jan 29;10:41. [39]. Wang Z, Zhang Q, Li Y,et al. Involvement of mitogen-activated protein kinases and nuclear factor kappa B pathways in signaling COX-2 expression in chronic rhinosinusitis. Inflammation research 2009 Oct;58(10):649-58. [40]. Huang X, Xi Y, Pan Q,et al. Caffeic acid protects against IL-1β-induced inflammatory responses and cartilage degradation in articular chondrocytes. Biomed Pharmacother 2018 Nov;107:433-439. [41]. Beroun A, Mitra S, Michaluk P,et al. MMPs in learning and memory and neuropsychiatric disorders. Cell Mol Life Sci 2019 Aug;76(16):3207-3228. [42]. Kapoor C, Vaidya S, Wadhwan V,et al. Seesaw of matrix metalloproteinases (MMPs). J Cancer Res Ther 2016 Jan-Mar;12(1):28-35. [43]. Sun L, Zhang Y, Zhang W,et al. Green tea and black tea inhibit proliferation and migration of HepG2 cells via the PI3K/Akt and MMPs signalling pathway. Biomed Pharmacother 2020 Jan 28;125:109893. [44]. Chan BYH, Roczkowsky A, Cho WJ, et al. MMP inhibitors attenuate doxorubicin cardiotoxicity by preventing intracellular and extracellular matrix remodeling. Cardiovasc Res 2020 Jan 29. pii: cvaa017. [45]. Wei B, Mao F, Guo Y, et al. Using 7.0T MRI T2 mapping to detect early changes of the cartilage matrix caused by immobilization in a rabbit model of immobilization-induced osteoarthritis. Magnetic Resonance Imaging 2015 Oct;33(8):1000-6. [46]. Kenzaka T. The Relationship between Remitting Seronegative Symmetrical Synovitis with Pitting Edema and Vascular Endothelial Growth Factor and Matrix Metalloproteinase 3. Intern Med 2020 Jan 17. [47]. 吕伟，时剑辉，崔巍等. MMP-1、MMP-3、MMP-13在兔骨关节炎软骨及滑膜中的表达. 中国卫生标准管理，2015, (23) ：191-192. [48]. 朱新辉, 徐大伟, 黄巍等. 膝关节骨性关节炎血液和滑液MMP-3水平与其病变程度的相关性[J]. 中国骨质疏松杂志, 2013, 19(3):203-206. [49]. Mogami H, Keller PW, Shi H, et al. Effect of thrombin on human amnion mesenchymal cells, mouse fetal membranes, and preterm birth. J Biol Chem 2014 May 9;289(19):13295-307. [50]. Anandacoomarasamy A, Caterson I, Sambrook P, et al. The impact of obesity on the musculoskeletal system.Int J Obes 2008;32:211–22. [51]. Mcalindon TE, Bannuru RR, Sullivan MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014 Mar;22(3):363-88. [52]. 李少彦. 心理护理对膝关节骨关节炎患者的临床干预效果. 临床医药文献杂志， 2017, 4(3)：502. [53]. Timmins KA, Leech RD, Batt ME, et al. Running and Knee Osteoarthritis: A Systematic Review and Meta-analysis. Am J Sports Med Am J Sports Med. 2017 May;45(6):1447-1457. [54]. ?iestad BE, Holm, Risberg MA. Return to pivoting sport after ACL reconstruction: association with osteoarthritis and knee function at the 15-year follow-up. Br J Sports Med 2018 Sep;52(18):1199-1204. [55]. 缪辉宇，曲崇正. 火针配合平衡针治疗膝骨关节炎的临床疗效[J]. 2020,50(1): 60-64. [56]. Goulet, Joseph L, Buta, Eugenia, Brennan, Matthew, et al. Discontinuing a non-steroidal anti-inflammatory drug (NSAID) in patients with knee osteoarthritis: Design and protocol of a placebo-controlled, noninferiority, randomized withdrawal trial. Contemp Clin Trials. 2018 Feb;65:1-7. [57]. Miller, Larry E, Sloniewsky, Michael J, Gibbons, Thomas E, et al. Long-term clinical benefit and cost-effectiveness of an 8-week multimodal knee osteoarthritis management program incorporating intra-articular sodium hyaluronate (Hyalgan((R))) injections. J Pain Res 2017 May 5; 10:1045-1054. [58]. Stott, Amanda. Hyaluronic Acid and Other Conservative Treatment Options for Osteoarthritis of the Ankle. Orthop Nurs 2017 Sep/Oct; 36(5):361-362. [59]. Trivedi S, Fang W, Ayyalasomayajula I, et al. Pharmacotherapeutic considerations and options for the management of osteoarthritis in women. Expert Opin Pharmacother 2020 Jan 31:1-10. [60]. Wellsandt E, Golightly Y. Exercise in the management of knee and hip osteoarthritis. Curr Opin Rheumatol 2018 Mar;30(2):151-159. [61]. Macías-Hernández SI, Morones-Alba JD, Miranda-Duarte A, et al. Glenohumeral osteoarthritis: overview, therapy, and rehabilitation. Disabil Rehabil 2017 Aug;39(16):1674-1682. [62]. Aweid O, Haider Z, Saed A, et al. Treatment modalities for hip and knee osteoarthritis: A systematic review of safety. J Orthop Surg (Hong Kong) 2018 May-Aug;26(3):2309499018808669. [63]. Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice. Lancet 2011 Jun 18;377(9783):2115-26. [64]. 郝玉彬.高效价糖皮质激素治疗膝骨性关节炎的临床研究,天津医科大学 2013. [65]. Savvidou O, Milonaki M, Goumenos S, et al. Glucocorticoid signaling and osteoarthritis. Mol Cell Endocrinol 2019 Jan 15;480:153-166. [66]. suzigan EM，Rocha EE，scala c. Poster 133 analysis of pain and func“onality jn knee osteoarth“tis panents aner sodium hyaluronate viscosupplemenlation．PM R.2016 8 (9S)：S205． [67]. Guidolin DD．Ronchetti IP，Lini E,et al. Morphological analysis of articular cartilage biopsies from a randomized，clinical sludy eo”paring the effects of 500·730 kDa sodium hyalumnate (Hyalgan) and methylprednisolone acetate on primary osteoanhritis of lhe knee．0sleoarthr canil 2001;9(4)： 371．381． [68]. Vasiliadjs Hs，Tsikopoulos K．Glucosine and chondroitin for the treatment of osteoarthritis．World J Orhtop 2017; 8 (1)：l—11. [69]. Bruyère O, Altman RD, Reginster JY. Efficacy and safety of glucosamine sulfate in the management of osteoarthritis: Evidence from real-life setting trials and surveys. Semin Arthritis Rheum 2016 Feb;45(4 Suppl):S12-7. [70]. 张文强,段春光,孟国林等. 降钙素基因相关肽对大鼠骨髓单核巨噬细胞破骨分化作用的实验研究.中国骨质疏松杂志,2015,(4):403-408. [71]. Katri A, D?browska A, L?fvall H, et al. A dual amylin and calcitonin receptor agonist inhibits pain behavior and reduces cartilage pathology in an osteoarthritis rat model. Osteoarthritis Cartilage 2019 Sep;27(9):1339-1346. [72]. Heiligenstein S，Cucchiarini M，Laschke MW，et al． In vitro and in vivo characterization of non biomedical and biomedical grade alginates for articular chondrocyte transplantation[J]．Tissue Eng Part C Methods 2011;4(2) 743，752. [73]. Kuroda T，Matsumoto T，Mifune Y，et al. Therapeutic strategy of third generation autologous chondrocyte implantation for osteoarthritis．Ups J Med Sci 2011 May;116(2):107-14. [74]. Clement RC, Haddix KP, Creighton RA, et al. Risk Factors for Infection After Knee Arthroscopy: Analysis of 595,083 Cases From 3 United States Databases. Arthroscopy 2016 Dec;32(12):2556-2561. [75]. 许颖，范凯健，王婷玉. 骨关节炎的发病机制及其药物治疗进展[J].实用药物与临床，2018,4(30):21-12. [76]. 周磊,曲铁兵,林源等. 腓骨近端截骨术治疗膝关节骨关节炎的疗效评价.中华老年骨科与康复电子杂志, 2016, 2(1): 16-20. [77]. 荆立忠,潘登,杨久山. 膝骨关节炎非全膝置换手术治疗研究进展.山东医药, 2016, 56(10):105-106. [78]. 张英泽,李存祥,李冀东等. 不均匀沉降在膝关节退变及内翻过程中机制的研究. 河北医科大学学报, 2014, 35(2): 218-219.